Mahmood Ladha has served as President and Head of Dova Pharmaceuticals since November 2019. Prior to joining Dova, Mahmood was a Senior Advisor to the CEO of Sobi and among other things led the acquisition of Dova Pharmaceuticals. With over 27 years of experiences in healthcare, Mahmood has held several senior leadership positions with AstraZeneca and Innovex. As the Head of US Marketing at AstraZeneca, he led and was accountable for three launches in the respiratory therapeutic area including Pulmicort Respules, Rhinocort Aqua and Accolate Peds. As Chief Operating Officer for Innovex, Mahmood was the architect and leader in implementing a change to the business model previously focused on large, primary sales forces to offering tailored solutions based on client needs.
While Vice President and Head of Transactions at AstraZeneca, Mahmood led dozens of completed deals including public and private company acquisitions (Ardea, Omthera), spinouts (Viela Bio), joint ventures (Samsung), in and out
licenses and various other partnership deals.
Mahmood earned a BS in marketing and an MBA from the University of South Carolina. He currently serves on the board of Life Sciences of PA.